Teacher Retirement System of Texas cut its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 16.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 53,671 shares of the company's stock after selling 10,865 shares during the quarter. Teacher Retirement System of Texas owned about 0.36% of U.S. Physical Therapy worth $4,761,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. KBC Group NV increased its stake in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock valued at $66,000 after purchasing an additional 315 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after acquiring an additional 298 shares in the last quarter. Intech Investment Management LLC bought a new position in U.S. Physical Therapy in the 3rd quarter valued at approximately $356,000. Quantbot Technologies LP increased its holdings in shares of U.S. Physical Therapy by 57.6% in the 3rd quarter. Quantbot Technologies LP now owns 10,876 shares of the company's stock worth $920,000 after purchasing an additional 3,973 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its stake in shares of U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock worth $1,425,000 after purchasing an additional 12,445 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. JPMorgan Chase & Co. cut their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. StockNews.com cut U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday, February 28th. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Finally, Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $109.00.
Read Our Latest Stock Analysis on U.S. Physical Therapy
Insider Transactions at U.S. Physical Therapy
In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.70% of the company's stock.
U.S. Physical Therapy Stock Performance
NYSE:USPH traded down $0.05 during mid-day trading on Thursday, hitting $72.82. 130,837 shares of the company traded hands, compared to its average volume of 100,003. The stock's fifty day moving average price is $83.90 and its 200-day moving average price is $86.73. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 77.47, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a one year low of $72.27 and a one year high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.47%. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 97.83%.
About U.S. Physical Therapy
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.